Petx just had a prelim study come out that showed promising results for dog for arthritis. The drug hasnt gone through any FDA channels as of yet and still has to undergo the certification process. They dont expect the drug to hit the market until 2016, which translated means no money until 2016 and thats if the FDA tests it and clears it. The options spread on this stock suck, so we are just going to go right ahead and short this one.
Aratana Therapeutics, Inc. (PETX)
-NasdaqGM Watchlist
15.48 2.41(18.44%)12:59PM EST - Nasdaq Real Time Price
Double Down on SGYPIn looking at the charts, I recommend a double down on SGYP. The price isnt really off that far on the 5.50s I got in on, but I made an error as the candle changed right before close to a power white candle with a long bottom…Read More
BMRN sell at 8.50This morning we are out of BMRN. Look at the spread below the last price was the previous trade as people are wating for further maximization of the drop,look at the bid and ask. Bid 7.70, ask 9.10.I get 8.50 with a limit ord…Read More
All Open Positions UpdateLets take a look at what we got open. SCHN, RDUS, QQQ, TNXP, and BMRN.
1) SCHN- Is going to announce next week. The stock is going sidways and has been for the last week or so. If what I think is going to happen happens, th…Read More
Exit RDUS short at even moneyExit the RDUS short. While BMRN worked out spectacularly as a overnight bounce, RDUS is a dog. If there is no movement, then we are out at even money from when we entered yesterday: No gain, no loss.
Later more today after…Read More
QQQ analysisThe Nasdaq was up today for several reasons. First and foremost the fed didn't raise the rates. So that was a shot in the arm for the markets. Second of all, a big milestone was reached, the NASDAQ finally surpassed March 10t…Read More
0 comments:
Post a Comment